Protein kinase C (PKC) was detected in the yeast Saccharomyces cerevisiae with bovine myelin basic protein as the phosphate acceptor. The enzyme was purified at least 500-fold by a four-step column chromatographic procedure (phenyl-Sepharose CL-4B, Mono Q, Heparin-5PW, and hydroxyapatite). The molecular mass was approximately 90 kDa, as estimated by gel-filtration analysis. Yeast PKC was activated by the simultaneous addition of Ca2+, diacylglycerol, and phosphatidylserine. Free arachidonic acid alone could activate the enzyme to some extent. However, yeast PKC did not respond significantly to tumor-promoting phorbol esters. GTP did not serve as phosphate donor. The yeast enzyme showed substrate specificity distinctly different from that of mammalian PKCs. H1 histone and protamine were poor substrates. With myelin basic protein as a model substrate, yeast PKC phosphorylated threonyl residues preferentially, whereas rat brain PKCs phosphorylated seryl residues preferentially. Further studies should elucidate the role of yeast PKC in cellular regulation and cell cycle control.
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Protein kinase C (PKC) plays a crucial role in the signal transduction pathways that control various physiological processes (1) . Biochemical, molecular cloning, and immunocytochemical analysis has revealed the existence of multiple subspecies of PKC in various mammalian tissues (for review, see ref. 1) as well as in other organisms such as Xenopus laevis (2) , Dictyostelium discoideum (3, 4) , sea urchin eggs (5) , and Drosophila (6, 7). Thorner et al. (8) have proposed the existence of an enzyme in Saccharomyces cerevisiae that possesses properties similar to those of mammalian PKC. This yeast enzyme would utilize protamine as substrate and require Ca2+, diacylglycerol (DG), and phosphatidylserine (PS) for its catalytic activity. In addition, these authors have isolated a gene that encodes a nucleotide sequence that is about 50% identical to the sequence of the mammalian PKC (8) . However, neither the enzymological properties nor the genetic and structural features of yeast PKC (yPKC) have been documented in detail. In the present studies we have confirmed the existence of PKC in the yeast S. cerevisiae. This enzyme, unlike mammalian PKCs, preferentially phosphorylates bovine myelin basic protein (MBP) rather than H1 histone and protamine and shows enzymological characteristics distinctly different from those of mammalian PKCs. yPKC will be described here and compared with the a subspecies of rat brain PKC (aPKC), which is the most common species in mammalian tissues and cell types.
MATERIALS AND METHODS
Yeast Strain and Culture. S. cerevisiae (strain IFO 10430; MATa pho 9-1 leu 2-3, 112 his 4-519 cani) was obtained from the Central Research Laboratories, Takeda Chemical Industries (Osaka) and cultured in the YPD medium [glucose (20 g/liter)/polypeptone (20 g/liter)/yeast extract (10 g/liter)] with continuous agitation at 30°C. This strain contained low protease activity. The cells, grown at 30°C for 16-20 hr until late-logarithmic phase, were employed for the present studies.
Chemicals. All chemicals were of analytical grade. Bovine brain MBP, protamine sulfate (from herring), kemptide, and soybean trypsin inhibitor were purchased from Sigma. [y-32P]ATP and [y-32P]GTP were obtained from New England Nuclear. Phospholipids, DGs, and free fatty acids were purchased from Serdary Research Laboratories (London, ON, Canada). Phorbol 12-myristate 13-acetate (PMA), phorbol 12,13-dibutyrate (PDBu), and 4a-phorbol 12,13-didecanoate (4aPDD) were the products of LC Services (Woburn, MA). Calf thymus H1 histone was prepared by the method of Oliver et al. (9) . The peptide substrates employed in the present studies were synthesized using an Applied Biosystems peptide synthesizer model 430A and were as follows: Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu , Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala [S6-(232-239)], and Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu {epidermal growth factor receptor-(650-658) [EGFR-(650-658)]}. These sequences are from MBP, ribosomal S6 protein, and EGFR, respectively, as indicated. Protease inhibitors such as leupeptin, antipain, pepstatin, and chymostatin were purchased from Peptide Institute (Osaka). (p-Amidinophenyl)methanesulfonyl fluoride hydrochloride (p-APMSF) was purchased from Wako Pure Chemical (Osaka). Other chemicals were obtained from commercial sources.
Enzyme and Assay. aPKC was purified from the rat brain cytosol as described (10) . yPKC and aPKC were routinely assayed by measuring the incorporation of 32p; into bovine MBP from [y-32P]ATP under the conditions essentially as described (11) . The standard reaction mixture (50 ,ul) contained 20 mM Tris Cl (pH 7.5), 10 mM MgCl2, 10 nated by spotting 40 ,ul of the reaction mixture onto P81 paper (Whatman). The paper was washed for five 5-min periods by immersion in about 10 ml of 75 mM H3PO4. Phosphorylation of H1 histone, protamine sulfate, and various synthetic peptides was similarly assayed. When casein was employed as substrate, 25% (wt/vol) trichloroacetic acid-insoluble materials were collected on a nitrocellulose filter. The radioactivity was quantitated using a scintillation spectrometer by Cerenkov counting.
Phospho Amino Acid Analysis. Phosphorylated amino acids were identified under the conditions described by Hunter and Sefton (12) . Briefly, MBP and H1 histone were extensively phosphorylated by either yPKC or aPKC in the presence of PS (80 Ag/ml), DO (8 jig/ml), and 10 jLM CaCl2 and subjected to SDS/PAGE analysis. The radioactive MBP or H1 histone was excised and hydrolyzed in 6 M HCI at 100°C for 3 hr. The hydrolyzates were subjected to thin layer electrophoresis (Polygram CEL-300) in the presence of authentic samples of phosphoserine, phosphothreonine, and phosphotyrosine, as described by Hunter and Sefton (12) . The standards were stained with ninhydrin, and the 32P-labeled amino acids were detected with autoradiography.
Molecular Mass Estimation. The molecular mass of yPKC was estimated by the gel-filtration procedure with a HiLoad 16/60 Superdex-200 column (1.6 x 60 cm), which was connected to an FPLC system (Pharmacia), equilibrated with 20 mM Tris Cl (pH 8.0) containing 0.5 mM EGTA, 0.5 mM EDTA, 2 mM dithiothreitol (DTT), and 200 mM NaCl. Samples (2 ml) were applied, and the proteins were eluted with the same buffer at a flow rate of 0.5 ml/min. Fractions (0.5 ml) were collected. Blue dextran was measured by absorbance at 625 nm for the void-volume determination. Aldolase (158 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), and ribonuclease A (13.7 kDa) were used as molecular mass standards.
RESULTS
Purification of yPKC. All manipulations were carried out at 0-40C. Cells [100 g (wet weight)] were suspended in 200 ml of 50 mM Tris Cl (pH 8.0) containing 1 mM EGTA, 1 mM EDTA, 5 mM DTT, leupeptin (100 ,ug/ml), 50 AMp-APMSF, antipain (0.5 mg/ml), pepstatin (0.5 mg/ml), chymostatin (0.5 mg/ml), and soybean trypsin inhibitor (0.5 mg/ml). The cell suspension was hoMogenized for 3 min by using a BeadBeater (Biospec Products, Bartlesville, OK) with 200 g of glass beads (0.5-mm diameter).
The resulting homogenate was centrifuged for 60 min at 100,000 x g and filtered through glass wool. The supernatant (180 ml, 2.1 g of protein), brought to 2 mM MgCl2 and 2 mM CaC12, was applied on a phenyl-Sepharose CL-4B column (Pharmacia, 2.6 x 10 cm) previously equilibrated with 20 mM Tris Cl (pH 8.0) containing 2 mM MgCl2, 2 mM CaC12, 1 mM EGTA, 1 mM EDTA, 2 mM DTT, leupeptin (50,ug/ml), 50 ,uM p-APMSF, antipain (10 ,ug/ml), pepstatin (10 ,ug/ml), chymostatin (10 ug/ml), and soybean trypsin inhibitor (10 ,ug/ml) at a flow rate of0.3 ml/min. After washing the column with 50 ml of the equilibration buffer, the enzyme was eluted batch-wise with 125 ml of 20 mM Tris Cl (pH 8.0) containing 10 mM EGTA, 2 mM DTT, leupeptin (50 ttg/ml), 50 ,uM p-APMSF, antipain (10 ,g/ml), pepstatin (10 ,g/ml), chymostatin (10 ,g/ml), and soybean trypsin inhibitor (10 ,ug/ml) at a flow rate of0.3 ml/min. The protein kinase in this eluate did not require PS and DG for enzymatic activity presumably due to some lipids that contaminated the preparation. The enzyme fraction (125 ml, 130 mg of protein) was directly applied on a Mono Q HR 16/10 column (Pharmacia, 1.6 x 10cm) that was connected to an FPLC system previously equilibrated with 20 mM Tris Cl (pH 8.0) containing 0.5 mM EGTA, 0.5 mM EDTA, 2 mM DTT, 5% (wt/vol) glycerol, leupeptin (50 Ag/ml), and 50 p.M p-APMSF (buffer A). The column was washed with 100 ml of buffer A at a flow rate of 3 ml/min. yPKC was eluted by application of a 360-ml linear concentration gradient of NaCl (0-0.5 M) in buffer A at a flow rate of 3 ml/min. Fractions (6 ml) were collected. When each fraction was assayed with MBP as phosphate acceptor in the presence of PS, DO, and Ca2+, one major and several minor peaks appeared (Fig. 1) .
Fractions 24-32 of the major peak (54 ml, 14 Fig. 2A shows a typical elution profile of the enzyme, which appeared again as a major peak with some shoulders. Rat brain PKC can be resolved into three subspecies by hydroxyapatite column chromatography (10), which are given in Fig. 2B from the phenyl-Sepharose CL-4B column was 100%, then this enzyme was purified at least 500-fold. By using MBP as a common phosphate acceptor protein, the yPKC preparation showed one-third the specific activity of an apparently pure aPKC preparation, although the phosphorylation sites by these enzymes were different (see below). Molecular Mass. The molecular mass of the main yPKC fraction was estimated.to be about 90 kDa by gel filtration. This value is slightly larger than that of mammalian PKCs (77-80 kDa). Ca2+ in the micromolar range was needed for maxi activity. Fig. 3B shows the kinetic properties of aPK comparison. With MBP as phosphate acceptor, a showed some activity with DO in the absence of PS at h Ca2+ concentrations. H1 histone was a poor substral yPKC (see below), but the reaction kinetics was simi that observed with MBP as shown in Fig. 3C . Fig. 3D (13) . It is particularly worth noting that yPKC was not significantly activated by PMA or PDBu. Fig. 4 shows the response of yPKC and aPKC to active and inactive phorbol esters under comparable conditions. 4aPDD was inactive toward yPKC and aPKC.
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Activation by Arachidonic Acid. Although the physiological 0. 4 significance has not been fully clarified, the mammalian PKCs are activated substantially in vitro by free unsaturated fatty acids, such as arachidonic acid and oleic acid, in the absence of added Ca2+ and PS (14, 15) . The kinetics of this activation varies greatly with the subspecies of PKC and also with the phosphate acceptors employed (16 Table  ,hows 1. Synthetic polypeptides such as MBP-(4-14), S6-(232-239), n the EGFR-(650-658), and kemptide, which are frequently used lId be as model substrates for the assay of mammalian PKCs, were ositol practically inactive for yPKC. Phospho amino acid analysis of MBP and H1 histone that were phosphorylated by yPKC was performed. The results in Fig. 6 indicate that yPKC preferentially phosphorylated threonyl residues, whereas aPKC phosphorylated seryl res- cell cycle control, we searched for the existence of PKC in lower eukaryotic cells such as yeast, since genetic manipulation of yeast is much easier. However, all attempts to detect PKC in yeast were unsuccessful until recently. Thorner et al. (8) proposed the existence of a PKC in S. cerevisiae that phosphorylates protamine and has enzymological characteristics similar to those of mammalian PKC. In the present studies, we have confirmed the presence of PKC in this organism, but the yPKC described herein utilizes MBP rather than H1 histone and protamine and has enzymological properties clearly different from those of the PKC family thus far isolated from mammalian tissues. The results presented above apparently show multiple species of yPKC, although a proteolytic artifact cannot be ruled out until structural analysis is done. The striking differences between yPKC and the mammalian PKC are that these enzymes clearly differ from each other in their substrate specificity and in their responses to tumor-promoting phorbol esters. It is possible that the yPKC described above is a different enzyme than that reported by Thorner et al. (8) . Thorner et al. (8) also isolated one gene from S. cerevisiae that showed 50% nucleotide sequence homology with the mammalian PKC sequence. However, the structural and genetic characterization of the yPKC remains to be done. Although the activation signal of yPKC is presently unknown, further enzymological and genetic studies may elucidate the physiological role of this protein kinase pathway in growth and cell cycle control.
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